Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: J Mol Cell Cardiol. 2016 Nov 8;101:90–98. doi: 10.1016/j.yjmcc.2016.11.002

Figure 5. BCKAs, but not BCAAs, protected cells against H2O2-induced death.

Figure 5

A, Cell viability analysis showing the effect of BCAAs- and BCKAs- replenishment on AML-12 murine hepotocyte survial. Cells were treated with BCAAs-free DMEM and then replenished with BCAAs (800 μM) or BCKAs (500 μM) and treated with H2O2 (500 μM). B, Cell viability analysis showing the effect of BCKAs on MEF cell death. Wildtype or PP2Cm deficient MEF cells were treated with BCKAs in presence or absence of H2O2 (500 μM).